Maravai Lifesciences Holdings (MRVI) Divestments (2021)
Maravai Lifesciences Holdings (MRVI) posted quarterly Divestments of $120.7 million for Q3 2021.
Maravai Lifesciences Holdings (MRVI) Divestments (2021) Analysis & Trends
Maravai Lifesciences Holdings' Divestments history runs 1 years deep, the most recent figure standing at $120.7 million for Q3 2021.
- In Q3 2021, Divestments changed N/A year-over-year to $120.7 million; the TTM figure through Dec 2023 stood at $120.7 million (changed N/A YoY), while the FY2022 annual figure was $620000.0, down 99.48% from the prior year.
- Divestments for Q3 2021 stood at $120.7 million.
- The five-year high for Divestments was $120.7 million in Q3 2021, with the low at $120.7 million in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 9.82 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -13.21 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Maravai Lifesciences Holdings | 1.48 Bn | 1.56 Bn | 20.65 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 120.70 Mn |